|
| |
|
MTU241
Multiple tumor and normal tissue array, with 12 major types of cancer paired with matched NAT, 12 cases/24 cores
|
|
| Microarray Panel: | Multiple tumor and normal tissue microarray, containing 12 major types of cancer (bladder, breast, colon, kidney, liver, lung, ovary, prostate, skin and uterus) paired with corresponding uninvolved tissues from the same patients |
| Cores: | 95 |
|
| Cases: | 12 |
| Layout: | 6 cols × 4 rows |
| Core Diameter: | 1.5 mm |
| Thickness: | 4 µm | | Quality Control: | H&E, IHC anti-Vimentin/Cytokeratin | | Applications: | Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page. |
| Notes: | Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure. |
*Tissue Microarray Slide Types:
- Unstained: unstained
paraffin
tissue microarray slide.
- Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
- H & E: Hematoxylin and Eosin stained tissue microarray slide.
Microarray Panel Display | Legend: | Bla - Bladder,
Bre - Breast,
GI- - GI-Colon,
Kid - Kidney,
Liv - Liver,
Lun - Lung,
Ova - Ovary,
Pro - Prostate,
Ski - Skin,
Ute - Uterus
 - Malignant tumor,
 - NAT
|
Specification Sheet
| Pos |
No. |
Sex |
Age |
Organ |
Pathology diagnosis |
Type † |
|
A1 |
1 |
M |
55 |
Bladder |
Transitional cell carcinoma |
Malignant |
|
A2 |
2 |
M |
55 |
Bladder |
Uninvolved bladder tissue of A1 |
NAT |
|
A3 |
3 |
F |
50 |
Breast |
Adenocarcinoma |
Malignant |
|
A4 |
4 |
F |
50 |
Breast |
Uninvolved breast tissue of A2 |
NAT |
|
A5 |
5 |
M |
56 |
GI-esophagus |
Squamous cell carcinoma |
Malignant |
|
A6 |
6 |
M |
56 |
GI-esophagus |
Uninvolved cervix tissue of A3 |
NAT |
|
B1 |
7 |
M |
58 |
GI-Stomach |
Adenocarcinoma |
Malignant |
|
B2 |
8 |
M |
58 |
GI-Stomach |
Uninvolved gastric tissue of A4 |
NAT |
|
B3 |
9 |
F |
74 |
GI-Colon |
Adenocarcinoma |
Malignant |
|
B4 |
10 |
F |
74 |
GI-Colon |
Uninvolved colon tissue of A5 |
NAT |
|
B5 |
11 |
M |
58 |
Kidney |
Clear cell carcinoma |
Malignant |
|
B6 |
12 |
M |
58 |
Kidney |
Uninvolved kidney tissue of A6 |
NAT |
|
C1 |
13 |
F |
52 |
Liver |
Hepatocellular carcinoma |
Malignant |
|
C2 |
14 |
F |
52 |
Liver |
Uninvolved liver tissue of C1 |
NAT |
|
C3 |
15 |
M |
53 |
Lung |
Squamous cell carcinoma |
Malignant |
|
C4 |
16 |
M |
53 |
Lung |
Uninvolved lung tissue of C2 |
NAT |
|
C5 |
17 |
F |
56 |
Ovary |
Adenocarcinoma |
Malignant |
|
C6 |
18 |
F |
56 |
Ovary |
Uninvolved ovary tissue of C3 |
NAT |
|
D1 |
19 |
M |
47 |
Prostate |
Adenocarcinoma |
Malignant |
|
D2 |
20 |
M |
47 |
Prostate |
Uninvolved prostate tissue of C4 |
NAT |
|
D3 |
21 |
M |
67 |
Skin |
Squamous cell carcinoma |
Malignant |
|
D4 |
22 |
M |
67 |
Skin |
Uninvolved skin tissue of C5 |
NAT |
|
D5 |
23 |
F |
36 |
Uterus |
Cervical squamous cell carcinoma |
Malignant |
|
D6 |
24 |
F |
36 |
Uterus |
Uninvolved uterus tissue of C6 |
NAT |
† For precise diagnosis, refer to pathology description.
Sorry, this tissue array cannot be compared to find overlapping cases.
|
